Mark Prissel, DPM
Foot & Ankle Surgery · Worthington, OHNPI 1700178035
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.7%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Paragon 28, Inc. at 45.5% of the total. Among foot & ankle surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 701 payments — averaging $1764.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$562K
- Medline Industries LP$510K
- Novastep Inc.$36K
- Restor3d, Inc.$30K
- International Life Sciences$27K
- GLW, Inc$14K
- plus $57K from 29 others
Across 8 payments — averaging $5441.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Paragon 28, Inc.$44K
Across 3 payments — averaging $18,126 each. An ownership or investment interest held by the physician or an immediate family member.
- GLW, Inc$54K
What the payments were for
- Royalty or licence$394,78432%
- Consulting fees$688,73556%
- Speaking & faculty fees$10,4001%
- Travel & lodging$109,4129%
- Food & beverage$28,9752%
- Education$4,1500%
- Gifts$2710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 221 | $562,425 |
| Medline Industries LP | 276 | $510,013 |
| Novastep Inc. | 39 | $36,227 |
| Restor3d, Inc. | 18 | $29,716 |
| International Life Sciences | 11 | $27,451 |
| GLW, Inc | 2 | $14,160 |
| Ossio Inc | 9 | $12,403 |
| Medshape, Inc. | 18 | $10,802 |
| Kuros Biosciences USA, Inc | 16 | $10,629 |
| Vilex LLC | 18 | $9,314 |
| Trilliant Surgical LLC. | 8 | $7,095 |
| Stryker(2 entities) | 27 | $2,354 |
| Medical Device Business Services, Inc. | 1 | $900 |
| Bone Support Inc. | 4 | $538 |
| Integra Lifesciences Corporation | 4 | $329 |
| Johnson & Johnson | 2 | $270 |
| Smith+Nephew | 2 | $237 |
| DJO, LLC | 2 | $204 |
| Sanara Medtech Inc. | 1 | $192 |
| Tenex Health Inc. | 2 | $143 |
| Kerecis Limited | 1 | $135 |
| Amniox Medical, Inc. | 1 | $117 |
| Crossroads Extremity Systems, LLC | 2 | $116 |
| Trimed, Inc. | 1 | $115 |
| Stimwave Technologies Incorporated | 2 | $102 |
| Orthofix Medical, Inc. | 1 | $101 |
| Abbott | 1 | $96 |
| Exactech, Inc. | 1 | $95 |
| Extremity Medical | 1 | $87 |
| Trice Medical, Inc. | 1 | $85 |
| Ortho Solutions Inc | 1 | $78 |
| Forma Medical | 1 | $69 |
| Pfizer | 4 | $55 |
| In2bones USA, LLC | 1 | $53 |
| 4web, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MEDLINE UNITE$765,873
- MEDLINE INDUSTRIES, INC.$487,151
- MEDLINE$445,582
- PENDING$222,791
- Product Portfolio$219,959
- Portfolio$218,086
- MJFS4536$82,121
- Dermatology and Wound Care$32,451
- FLEXBAND$20,473
- MagnetOs$10,458
- DynaNail$8,039
- DynaNail Helix, Washer, 15 mm$7,590
- HINTERMANN$5,878
- Medline Unite Foot Plating System$5,472
- PRESSLOCK Compression Locking Plates$4,491
- Apollo$2,605
- ALPHALOK$2,295
- AIRLOCK Forefoot/Midfoot Plating$2,000
- Flatfoot$1,653
- Hammertube Sterile Implant Kits$1,329
How this compares
$1,236,726 in reported general payments places this provider in the 95th percentile of 429 foot & ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 38 | $115 |
| Cephalexin | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Worthington
- Christopher HyerWorthington$4.7M
- Roberto BrandaoWorthington$151K
- Travis LanganWorthington$141K
- Patrick BullWorthington$95K
- Sarah AbshierWorthington$33K
- Devon ConsulWorthington$32K
- David GossWorthington$29K
- Cameron MeyerWorthington$20K
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.